논문번호 | 19 | ||
논문제목(영문) | Clinical and angiographic characteristics of coronary artery ectasia. | ||
국내외구분 | 국내 | SCI여부 | SCI(E) |
연구책임자역할 | 교신저자 | ||
주저자명 | Kim W | ||
교신저자명 | Jeong MH | ||
공동저자명 | Kim W, Jeong MH, Kim KH, Kim KH, Lee SW, Kim NH, Ahn Y, Cho JG, Park JC, Kang JC; | ||
게제년월일 | 1999-09-25 | ||
ISSN | 1738-5520 | ||
Impact Factor | 0.753 | ||
학술지명 | Korean Circulation J | ||
서지사항 | 0집 / 30권 / 10호, 페이지(1205 - 1212) | ||
요약초록문 (Abstract) 입력 |
Background:Coronary artery ectasia is an abnormal enlargement of coronary artery and infrequently associated with acute coronary syndrome. The prognosis, treatment, and etiology of this disease remain unclear. Method:Sixtyone patients (35 male and 26 female, 53±11.0 years) out of 4,694 patients who underwent diagnostic coronary angiography at Chonnam National University Hospital between January 1996 and March 1999, and diagnosed as isolated coronary artery dilatatation without significant stenosis, were analyzed retrospectively. Results:The incidence of coronary artery ectasia on the coronary angiography was 1.29%. Smoking was the most frequently associated risk factor. Clinical diagnosis was 16 (26.2%) cases of stable angina, 29 (47.5%) unstable angina, 9 (14.7%) acute myocardial infarction, 5 (8.1%) old myocardial infarction, and 2 (3.3%) variant angina. Right coronary artery was the most frequent involved artery (42.5%). Type Ⅰ according to Markins’classification was 63.9%. Proximal part of coronary artery was the most common involved arterial segment. Aspirin (78.7%), calcium antagonist (73.8%), nitrate (29.5%) and β-blocker (12%) were used. During clinical follow-up of 12±10.5 months, there were no major cardiac event in all patients. Conclusion:The incidence of the coronary artery ectasia in Korean patients was relatively rare, and long-term prognosis was good. |
||
파일 |
C17. Korean Circulation J 2000;30(10)1205-1212..pdf (1.5M) DATE : 2016-03-14 11:50:02 |
전라남도 장성군 남면 삼태리 산 109 나노바이오연구원 3층 306호 TEL : 061-392-6243 Fax: 061-392-6243
Copyright ⓒ 2014 Korea Cardiovascular Stent Research Institute. All right Reserved